Characteristic | Low arterial stiffness group (%) | High arterial stiffness group (%) | P value |
---|---|---|---|
Gender | |||
 Male | 19 (65.5) | 48 (66.7) | 0.912 |
 Female | 10 (34.5) | 24 (33.3) | |
Diabetes | |||
 No | 21 (72.4) | 36 (50.0) | <0.001* |
 Yes | 8 (27.6) | 36 (50.0) | |
Metabolic syndrome | |||
 No | 22 (75.9) | 16 (22.2) | <0.001* |
 Yes | 7 (24.1) | 56 (77.8) | |
ACE inhibitor use | |||
 No | 17 (58.6) | 47 (65.3) | 0.530 |
 Yes | 12 (41.4) | 25 (34.7) | |
ARB use | |||
 No | 14 (48.3) | 31 (43.1) | 0.633 |
 Yes | 15 (51.7) | 41 (56.9) | |
β-blocker use | |||
 No | 12 (41.4) | 33 (45.8) | 0.684 |
 Yes | 17 (58.6) | 39 (54.2) | |
CCB use | |||
 No | 15 (51.7) | 42 (58.3) | 0.544 |
 Yes | 14 (48.3) | 30 (41.7) | |
Thiazide use | |||
 No | 23 (78.3) | 57 (79.2) | 0.987 |
 Yes | 6 (20.7) | 5 (20.8) | |
Statin | |||
 No | 12 (41.4) | 31 (43.1) | 0.877 |
 Yes | 17 (58.6) | 35 (56.9) |  |
Fibrate | |||
 No | 23 (79.3) | 64 (88.9) | 0.208 |
 Yes | 6 (20.7) | 5 (11.3) |  |